Drug Recall: Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai 400 030, India, Distri
JB Chemicals and Pharmaceuticals Ltd · April 23, 2026
Reason for Recall
Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test
Product Description
Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai 400 030, India, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 64980-688-10.
Distribution
Nationwide in the USA
States Affected
NATIONWIDE
Quantity Affected
675 bottles
Source: FDA (openFDA Drug Enforcement)
Recall number: D-0520-2026
Status: ongoing
SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.